These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17691958)

  • 1. Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide?
    Mathrani VC; Kenyon NJ; Zeki A; Last JA
    Curr Med Chem; 2007; 14(20):2204-13. PubMed ID: 17691958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Redington AE
    Eur J Pharmacol; 2006 Mar; 533(1-3):263-76. PubMed ID: 16466650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.
    Kharitonov SA
    Vascul Pharmacol; 2005 Dec; 43(6):371-8. PubMed ID: 16198155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma.
    Mabalirajan U; Ahmad T; Leishangthem GD; Joseph DA; Dinda AK; Agrawal A; Ghosh B
    J Allergy Clin Immunol; 2010 Mar; 125(3):626-35. PubMed ID: 20153031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbidities.
    van den Berg MP; Meurs H; Gosens R
    Curr Opin Pharmacol; 2018 Jun; 40():126-133. PubMed ID: 29729549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediators of asthma: nitric oxide.
    Fischer A; Folkerts G; Geppetti P; Groneberg DA
    Pulm Pharmacol Ther; 2002; 15(2):73-81. PubMed ID: 12090780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibition: therapeutic potential in asthma.
    Mulrennan SA; Redington AE
    Treat Respir Med; 2004; 3(2):79-88. PubMed ID: 15182209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease.
    Ricciardolo FL; Nijkamp FP; Folkerts G
    Curr Drug Targets; 2006 Jun; 7(6):721-35. PubMed ID: 16787174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saponin-enriched extract of Asparagus cochinchinensis alleviates airway inflammation and remodeling in ovalbumin-induced asthma model.
    Sung JE; Lee HA; Kim JE; Yun WB; An BS; Yang SY; Kim DS; Lee CY; Lee HS; Bae CJ; Hwang DY
    Int J Mol Med; 2017 Nov; 40(5):1365-1376. PubMed ID: 28949387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
    Hansel TT; Kharitonov SA; Donnelly LE; Erin EM; Currie MG; Moore WM; Manning PT; Recker DP; Barnes PJ
    FASEB J; 2003 Jul; 17(10):1298-300. PubMed ID: 12738811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity.
    Ibba SV; Ghonim MA; Pyakurel K; Lammi MR; Mishra A; Boulares AH
    Mediators Inflamm; 2016; 2016():1984703. PubMed ID: 27524861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of exhaled nitric oxide in the diagnosis and management of asthma.
    Majid H; Kao C
    Curr Opin Pulm Med; 2010 Jan; 16(1):42-7. PubMed ID: 19797954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol attenuates oxidative stress and inflammation in a guinea pig model of ovalbumin-induced asthma: a possible mechanism for its favorable respiratory effects.
    Abuelezz SA
    Can J Physiol Pharmacol; 2018 Mar; 96(3):258-265. PubMed ID: 29319332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase expression is increased in the alveolar compartment of asthmatic patients.
    Tufvesson E; Andersson C; Weidner J; Erjefält JS; Bjermer L
    Allergy; 2017 Apr; 72(4):627-635. PubMed ID: 27647044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis.
    Batra J; Chatterjee R; Ghosh B
    Indian J Biochem Biophys; 2007 Oct; 44(5):303-9. PubMed ID: 18341205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioenergetic Differences in the Airway Epithelium of Lean
    Winnica D; Corey C; Mullett S; Reynolds M; Hill G; Wendell S; Que L; Holguin F; Shiva S
    Antioxid Redox Signal; 2019 Oct; 31(10):673-686. PubMed ID: 30608004
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies.
    Domenico R
    Curr Pharm Des; 2004; 10(14):1667-76. PubMed ID: 15134564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma.
    North ML; Khanna N; Marsden PA; Grasemann H; Scott JA
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L911-20. PubMed ID: 19286931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine and asthma.
    Morris CR
    Nestle Nutr Inst Workshop Ser; 2013; 77():1-15. PubMed ID: 24107492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness.
    Hjoberg J; Shore S; Kobzik L; Okinaga S; Hallock A; Vallone J; Subramaniam V; De Sanctis GT; Elias JA; Drazen JM; Silverman ES
    J Appl Physiol (1985); 2004 Jul; 97(1):249-59. PubMed ID: 15020581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.